Impact and effectiveness of meningococcal vaccines: a review

Oliveira, Lucia Helena De; Jauregui, Barbara; Carvalho, Ana Flavia; Giglio, Norberto.
Rev. panam. salud pública ; 41: e158, 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-961652

Documentos relacionados

  1. [<b>A phase</b> Ⅲ <b>clinical trial study on the safety and immunogenicity of ACYW135 group meningococcal conjugate vaccine inoculated in 3 month old infants</b>].
  2. Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study.
  3. Propositive follow-up: Long-term immune responses to the 4CMenB and MenACWY vaccines in people living with HIV.
  4. Meningococcal Vaccine in Mali and Gambia. Reply.
  5. Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children.
  6. Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia.
  7. Evaluation of candidate international standards for meningococcal serogroups A and X polysaccharide.
  8. Re-randomization tests as sensitivity analyses to confirm immunological noninferiority of an investigational vaccine: Case study.
  9. Optimization of hydrolysis conditions of amino acid analysis for UHPLC-UV antigens content determination: Bexsero vaccine a case study.
  10. The propositive study: Immunogenicity and safety of a four-component recombinant protein-based vaccine against MenB and a quadrivalent conjugate MenACWY vaccine in people living with HIV.